First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Declares Quarterly Dividend of $0.09

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) announced a quarterly dividend on Wednesday, June 24th, NASDAQ Dividends reports. Shareholders of record on Thursday, June 25th will be paid a dividend of 0.092 per share on Tuesday, June 30th. This represents a c) annualized dividend and a yield of 1.0%. The ex-dividend date is Thursday, June 25th. This is a 60.6% increase from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

FTXH stock traded up $0.34 during midday trading on Thursday, reaching $37.12. 2,522 shares of the company were exchanged, compared to its average volume of 7,698. The business has a 50-day moving average price of $34.71 and a two-hundred day moving average price of $34.18. First Trust Nasdaq Pharmaceuticals ETF has a one year low of $25.58 and a one year high of $37.60. The firm has a market capitalization of $33.41 million, a price-to-earnings ratio of 14.51 and a beta of 0.47.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

A number of hedge funds have recently modified their holdings of the stock. NBC Securities Inc. boosted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 33.0% during the 4th quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock worth $44,000 after buying an additional 329 shares during the period. Kestra Advisory Services LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter valued at about $59,000. Raymond James Financial Inc. bought a new position in First Trust Nasdaq Pharmaceuticals ETF in the 2nd quarter valued at about $57,000. Flagship Harbor Advisors LLC acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter worth approximately $205,000. Finally, Flputnam Investment Management Co. acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter worth approximately $230,000.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.